In fiscal 2025, which ended Dec 31, 2025, Israel Acquisitions Corp used $258,324 of cash from operations, down 107.7% from the year before. The company returned $73.5 million in share buybacks to shareholders.
USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
|---|---|---|---|---|
| Operating | ||||
| Operating cash flow |
-0
-110.9%
|
-0
-107.7%
|
3
+1022.0%
|
-0
|
| Investing | ||||
| Investing cash flow |
3
-95.5%
|
73
+2.2%
|
71
+148.3%
|
-147
|
| Financing | ||||
| Stock buybacks |
4
-95.0%
|
74
-3.1%
|
76
|
—
|
| Financing cash flow |
-3
+95.8%
|
-72
+3.6%
|
-75
-150.7%
|
148
|
| Change in cash | ||||
| Net change in cash |
-0
-474.3%
|
-0
+97.8%
|
-1
-198.0%
|
1
|
| Shareholder returns | ||||
| Returned to shareholders |
4
|
74
|
76
|
—
|
| Ratios | ||||
| Cash conversion |
—
|
—
|
1.19x
|
-0.06x
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.
Company profile
- Industry
- Blank Checks (SIC 6770)
- Listed as
- ISRLF (OTC), ISLUF (OTC), ISLWF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Bee Cave, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1915328
Other Blank Checks companies
- Drugs Made In America Acquisition II Corp. DMII
- EQV Ventures Acquisition Corp. II EVAC
- Bain Capital GSS Investment Corp. BCSS
- Cantor Equity Partners IV, Inc. CEPF
- Churchill Capital Corp XII CXII
- American Exceptionalism Acquisition Corp. A AEXA
- New America Acquisition I Corp. NWAX
- Ares Acquisition Corp III AAC
Source: SEC EDGAR filings. This is company-reported data, not investment advice.